{
	"kj8tw1ucText": "Study Design",
	"kj8tw1udText": "Goal At<span class=\"_ _0\"></span>tainment Scale (GAS) mean score and change fr<span class=\"_ _0\"></span>om baseline, ",
	"kj8tw1ueText": "by visit",
	"kj8tw1ufText": "P<span class=\"_ _0\"></span>atie<span class=\"_ _0\"></span>nts with a pa<span class=\"_ _0\"></span>r<span class=\"_ _1\"></span>tial re<span class=\"_ _0\"></span>spo<span class=\"_ _0\"></span>nse t<span class=\"_ _0\"></span>o thei<span class=\"_ _0\"></span>r pri<span class=\"_ _0\"></span>or <br><span class=\"ls11 ws2b\">antidepressant<span class=\"_ _1\"></span> t<span class=\"_ _1\"></span>reatment<span class=\"_ _1\"></span> achiev<span class=\"_ _2\"></span>ed<span class=\"_ _1\"></span> their per<span class=\"_ _1\"></span>sonalised <br>t<span class=\"_ _1\"></span>reatment<span class=\"_ _1\"></span> goals<span class=\"fs2 ls0 ws3a v1\">†</span><span class=\"ls0 wsa\"> withi<span class=\"_ _0\"></span>n 1<span class=\"_ _30\"></span>2 w<span class=\"_ _0\"></span>eeks after star<span class=\"_ _1\"></span>ting o<span class=\"_ _0\"></span>n Bri<span class=\"_ _0\"></span>nte<span class=\"_ _0\"></span>lli<span class=\"_ _0\"></span>x®<span class=\"_ _2\"></span><span class=\"fs2 v1\">1</span></span></span>",
	"kj8tw1ugText": "† <span class=\"fs17 ls1e wsa v6\">P<span class=\"_ _0\"></span>re-identified treatment goals agreed between the individual patient and physician as demonstr<span class=\"_ _0\"></span>ated by a GAS-D score of ≥50 at week 12; *** p-value &lt;0.001. T<span class=\"_ _2\"></span>otal n=116. <br>Standard deviation a<span class=\"_ _0\"></span>t baseline=0.07; at 6 weeks=11.46; at 12 weeks=13.58. GAS-D<span class=\"_ _0\"></span>, Goal At<span class=\"_ _0\"></span>tainment Scale adapted for Depression.</span>",
	"kj8tw1uhText": "In an open-label study<span class=\"_ _0\"></span>, significant impr<span class=\"_ _0\"></span>ovements from baseline in GAS-D score wer<span class=\"_ _0\"></span>e observed after  <span class=\"_ _31\"> </span> <span class=\"_ _32\"> </span> <span class=\"_ _32\"> </span> <br>12 weeks of Brintellix® treatment in patients with MDD and par<span class=\"_ _0\"></span>tial response to antidepressant tr<span class=\"_ _0\"></span>eatment<span class=\"fsf v3\">1</span>",
	"kj8tw1uiText": "58% of patients treated with Brintellix® achieved their personalised tr<span class=\"_ _0\"></span>eatment goals<span class=\"fsf v3\">1</span>",
	"kj8tw1ujText": "Mean GAS score (SDS)",
	"kj8tw1ukText": "Change from baseline",
	"kj8tw1ulText": "Brintellix® 10-20 mg",
	"kj8tw1umText": "Baseline (Day 1)<span class=\"_ _33\"></span>Visits<span class=\"_ _34\"> </span>Week 12<span class=\"_ _35\"></span>Week 6",
	"kj8tw1unText": "Change from baseline",
	"Brintellix_3874f286a6": "Text",
	"Brintellix_3867f0522f": "Text",
	"Brintellix_3893ce38ca": "Text",
	"Brintellix_38a5d20c60": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 25px;\">References</font>\n</span>",
	"Brintellix_38b20a3a64": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>1.</b> McCue M et al. Poster presented at ASCP.P232. 2018.\n<br>\n</font>\n</span>",
	"Brintellix_3823d84007": "Text",
	"Brintellix_386056f34a": "Text",
	"Brintellix_38138c1708": "Text",
	"Brintellix_38ad30169a": "Text",
	"Brintellix_38e7e541be": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;color: #4d7f86;\">Cognitive Symptoms&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Functionality&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Motivation &amp; Energy&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"color: #fff;\">Goal Attainment</span></div>"
}
